Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Diagnosis & Therapy|November 29, 2012
Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicineSandjar Djalalov, Jean Yong, Jaclyn Beca, et al.
Archives of Women'S Mental Health|March 10, 2016
Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Psychological Assessment|May 5, 2015
The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Research in Nursing & Health|April 19, 2012
Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants studyFatiha Karam, Anick Bérard, Odile Sheehy, et al.
Paediatrics & Child Health|December 1, 2025
Mental disorders among postpartum individuals with medically high-risk infants and/or obstetrical complications: A population requiring further attentionLaura Diamond, Kayla Esser, Myla Moretti, et al.
International Journal of Integrated Care|May 18, 2022
Implementing a Care Coordination Strategy for Children with Medical Complexity in Ontario, Canada: A Process EvaluationSamantha Quartarone, Jia Lu Lilian Lin, Julia Orkin, et al.
American Journal of Perinatology|October 3, 2002
Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international studyMatitiahu Berkovitch, Paul Mazzota, Revital Greenberg, et al.
JAMA Network Open|February 9, 2022
Prevalence, Cost, and Variation in Cost of Pediatric Hospitalizations in Ontario, CanadaPeter J Gill, Thaksha Thavam, Mohammed Rashidul Anwar, et al.
JAMA Network Open|May 13, 2025
Integrated Collaborative Care for Youths With Mental Health and Substance Use Challenges: A Randomized Clinical TrialJo Henderson, Peter Szatmari, Kristin Cleverley, et al.
Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.
Pageof 4